Kaya Holdings (KAYS) Change in Accured Expenses (2011 - 2025)
Kaya Holdings (KAYS) recorded quarterly Change in Accured Expenses of -$338678.0 in Q3 2025, down 190.78% quarter-over-quarter from $373060.0 in Q2 2025, and down 943.53% on a YoY basis from $40150.0 in Q3 2024.
Kaya Holdings (KAYS) Change in Accured Expenses (2011 - 2025) Analysis & Trends
Kaya Holdings' Change in Accured Expenses history runs 15 years deep, the most recent figure standing at -$338678.0 for Q3 2025.
- In Q3 2025, Change in Accured Expenses fell 943.53% year-over-year to -$338678.0; the TTM figure through Sep 2025 stood at $641111.0 (up 1464.73% YoY), while the FY2024 annual figure was $646662.0, up 823.54% from the prior year.
- Change in Accured Expenses was -$338678.0 for Q3 2025 at Kaya Holdings, down from $373060.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $589647.0 in Q4 2024 to a low of -$338678.0 in Q3 2025.
- Historically, Change in Accured Expenses has averaged $62687.4 across 5 years, with a median of $17082.0 in 2025.
- Biggest YoY gain for Change in Accured Expenses was 1369.35% in 2024; the steepest drop was 1011.51% in 2024.
- A 5-year view of Change in Accured Expenses shows it stood at $420348.0 in 2021, then slumped by 102.38% to -$10024.0 in 2022, then plunged by 937.43% to -$103992.0 in 2023, then surged by 667.01% to $589647.0 in 2024, then sank by 157.44% to -$338678.0 in 2025.
- The last three Change in Accured Expenses figures came in at -$338678.0 (Q3 2025), $373060.0 (Q2 2025), and $17082.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | -14.30 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 23.00 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 14.53 Mn |
| 10 | Kaya Holdings | - | - | 5,370.00 | -338,678.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -338,678.00 |
| Sep 30, 2025 | -338,678.00 |
| Jun 30, 2025 | 373,060.00 |
| Jun 30, 2025 | 373,060.00 |
| Mar 31, 2025 | 17,082.00 |
| Mar 31, 2025 | 17,082.00 |
| Dec 31, 2024 | 589,647.00 |
| Dec 31, 2024 | 589,647.00 |
| Sep 30, 2024 | 40,150.00 |
| Sep 30, 2024 | 40,150.00 |
| Jun 30, 2024 | -144,863.00 |
| Jun 30, 2024 | -144,863.00 |
| Mar 31, 2024 | 161,728.00 |
| Mar 31, 2024 | 161,728.00 |
| Dec 31, 2023 | -103,992.00 |
| Dec 31, 2023 | -103,992.00 |
| Sep 30, 2023 | 40,391.00 |
| Sep 30, 2023 | 40,391.00 |
| Jun 30, 2023 | -13,033.00 |
| Jun 30, 2023 | -13,033.00 |